Mebidal 50 mg (Tablet)
Medicine Details
| Category | Details |
|---|---|
| Generic | Mebhydrolin napadisylate |
| Company | Eskayef pharmaceuticals ltd |
Indications
- Allergic disease or symptoms such as urticaria
- Pruritus of various origin
- Eczema
- Itching
- Drug rash
- Insect bites
- Allergic conjunctivitis
- Dermatitis of nutritional origin
- Hay fever
- Vasomotor rhinitis
- Allergic asthma
Pharmacology
Mebhydrolin diminishes or abolishes the main actions of histamine in the body by blocking of histamine receptors.
Dosage & Administration
Adults and children over 10 years: 2-6 tablets daily. Children: 5-10 years: 2-4 tablets daily, 2-5 years: 1-3 tablets daily, Up to 2 years: 1-2 tablets daily. Treatment should be given in several single doses daily. Mebhydrolin may be swallowed during or shortly after meals. For children, the tablet may be crushed and mixed with food.
Interaction
The effects of atropine and tricyclic anti-depressants may be enhanced by Mebidal. It may mask the warning symptoms of damage caused by ototoxic drugs.
Contraindications
- Hypersensitivity to any of the ingredients of Mebhydrolin tablet or to mebhydrolin
- Prostatic hypertrophy, narrow-angle glaucoma
- First trimester of pregnancy
Side Effects
- Lassitude
- Dizziness
- Hypotension
- Muscular weakness
- Nausea
- Vomiting
- Diarrhoea or constipation
- Epigastric pain
- Headache
- Blurred vision
- Tinnitus
- Depression
- Nightmares
- Anorexia
- Dryness of the mouth
- Tightness of the chest
- Tingling
- Sedation
- Drowsiness
Pregnancy & Lactation
Safety in pregnancy and lactation has not been established.
Precautions & Warnings
The substance may cause drowsiness, if affected, driving or operating machinery & alcoholic drinks should be avoided.
Use in Special Populations
Safety in pregnancy and lactation has not been established.
Therapeutic Class
Sedating Anti-histamine
Storage Conditions
Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.